Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia
Completed · Not applicable
Conditions studied: Ventilator-Associated Pneumonia
In brief
The proposed study will evaluate adult patients admitted to the medical or surgical intensive care units (ICUs) at San Francisco General Hospital (SFGH). On admission, patients will be randomized in a 1:1 manner to the mini-bronchoalveolar lavage (BAL) quantitative culture arm in the setting of suspected ventilator-associated pneumonia (VAP) versus the tracheal aspirate culture arm, which is the current test available at SFGH.
Key facts
- Study ID
- NCT00319644
- Run by
- University of California, San Francisco
- People needed
- 37
- Starts
- 2006-05-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2012-11-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All adult patients (> age 18) admitted to 5E, 5R, and 4E intensive care units and are on the ventilator for greater than 48 hours and expected to remain on the ventilator for awhile
- Study procedures would be performed only in patients clinically suspected of having VAP.
You may not qualify if…
- Severe respiratory distress at the time of suspected VAP defined by:
- FiO2 ≥ 0.7
- PEEP ≥ 12
Where it is running
- San Francisco General Hospital — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.